We are live on
!
Find out more
TD Asset Management Portfolio holdings
AUM
$123B
1-Year Est. Return
34.51%
This Fund
S&P 500
This Quarter
Est. Return
-15.11%
1 Year Est. Return
+34.51%
3 Year Est. Return
+98.94%
5 Year Est. Return
+122.3%
10 Year Est. Return
+375.56%
AUM
$86.3B
AUM Growth
-$23B
(-21%)
Cap. Flow
-$4.73B
Cap. Flow
% of AUM
-5.48%
Top 10 Holdings %
Top 10 Hldgs %
27.54%
Holding
1,537
New
55
Increased
353
Reduced
823
Closed
80
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$311M |
| 2 |
UnitedHealth
UNH
|
+$143M |
| 3 |
Stryker
SYK
|
+$139M |
| 4 |
Tesla
TSLA
|
+$133M |
| 5 |
Northrop Grumman
NOC
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.77B |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$419M |
| 3 |
Meta Platforms (Facebook)
META
|
+$291M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$258M |
| 5 |
Comcast
CMCSA
|
+$154M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.12% |
| 2 | Technology | 17.73% |
| 3 | Healthcare | 10.68% |
| 4 | Consumer Discretionary | 8.18% |
| 5 | Communication Services | 8.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Copart
CPRT
$27B
| $18.2M | 0.02% |
670,720
+49,500
| +8% | +$1.41M |
|
452
Ultragenyx Pharmaceutical
RARE
$2.45B
| $18.1M | 0.02% |
304,227
-54,114
| -15% | -$3.33M |
|
453
DexCom
DXCM
$32.2B
| $18.1M | 0.02% |
242,466
-2,002
| -0.8% | -$183K |
|
454
Norfolk Southern
NSC
$75.4B
| $18M | 0.02% |
79,180
-2,640
| -3% | -$648K |
|
455
Sun Communities
SUI
$15.2B
| $18M | 0.02% |
112,830
-2,135
| -2% | -$358K |
|
456
Steris
STE
$22.3B
| $18M | 0.02% |
87,194
-17,682
| -17% | -$3.99M |
|
457
Alexandria Real Estate Equities
ARE
$8.97B
| $17.9M | 0.02% |
123,395
-78,590
| -39% | -$13.3M |
|
458
Markel Group
MKL
$23.3B
| $17.8M | 0.02% |
13,741
-433
| -3% | -$594K |
|
459
General Dynamics
GD
$104B
| $17.7M | 0.02% |
79,796
-1,854
| -2% | -$427K |
|
460
Marathon Petroleum
MPC
$92.4B
| $17.6M | 0.02% |
214,660
-21,605
| -9% | -$2.02M |
|
461
Illumina
ILMN
$31B
| $17.6M | 0.02% |
98,227
-1,533
| -2% | -$391K |
|
462
ResMed
RMD
$30.6B
| $17.4M | 0.02% |
83,083
-5,816
| -7% | -$1.24M |
|
463
Parker-Hannifin
PH
$123B
| $17.2M | 0.02% |
69,935
+8,899
| +15% | +$2.38M |
|
464
Bunge Global
BG
$20.4B
| $17.2M | 0.02% |
189,399
+21,895
| +13% | +$2.43M |
|
|
GTPB
465
DELISTED
Gores Technology Partners II, Inc. Class A Common
GTPB
| $17.1M | 0.02% |
1,750,000
| – | – |
|
466
Reynolds Consumer Products
REYN
$5.26B
| $17.1M | 0.02% |
626,200
-15,800
| -2% | -$443K |
|
|
KVSC
467
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
| $17M | 0.02% |
1,750,000
| – | – |
|
468
Labcorp
LH
$25.4B
| $17M | 0.02% |
84,391
-8,670
| -9% | -$1.85M |
|
469
Nexstar Media Group
NXST
$5.82B
| $16.9M | 0.02% |
103,985
+30,361
| +41% | +$5.13M |
|
470
Idexx Laboratories
IDXX
$44.1B
| $16.9M | 0.02% |
48,271
-1,626
| -3% | -$663K |
|
471
Manhattan Associates
MANH
$11.2B
| $16.9M | 0.02% |
147,627
+3,620
| +3% | +$451K |
|
472
Sempra
SRE
$57.9B
| $16.9M | 0.02% |
225,058
-11,410
| -5% | -$916K |
|
473
Allstate
ALL
$68B
| $16.9M | 0.02% |
133,335
-73,000
| -35% | -$9.56M |
|
474
T. Rowe Price
TROW
$23.9B
| $16.8M | 0.02% |
148,071
-23,213
| -14% | -$2.95M |
|
475
Moody's
MCO
$82.8B
| $16.8M | 0.02% |
61,842
-1,521
| -2% | -$455K |
|
Similar funds
VAM
TD Asset Management's Q2 2022 Portfolio in Review
As of Q2 2022, TD Asset Management held 1,537 positions worth $86.3B, down 21% from $109B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
TD Asset Management withdrew a net $4.73B in Q2 2022, closing 80 positions and reducing 823 holdings. Its most notable exit was Ortho Clinical Diagnostics Holdings plc Ordinary Shares, an estimated $23.8M position sold in full.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.
Against the trend, TD Asset Management opened a new position in Vanguard Short-Term Corporate Bond ETF worth $25M.
- TD Asset Management's largest Q2 2022 buy was Vanguard Short-Term Corporate Bond ETF: 327,600 shares worth $25M.
- TD Asset Management added most to iShares 20+ Year Treasury Bond ETF in Q2 2022, an estimated $311M increase.
- TD Asset Management's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.77B.
- TD Asset Management fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $23.8M.
- TD Asset Management's ten largest holdings make up 28% of its $86.3B portfolio in Q2 2022.
- TD Asset Management opened 55 new positions and closed 80 in Q2 2022.
- TD Asset Management's portfolio value fell 21% quarter-over-quarter to $86.3B.
Based on TD Asset Management's 13F filing for Q2 2022, filed 4 Aug 2022.